OTC Pharmaceuticals - Iran

  • Iran
  • Revenue in the OTC Pharmaceuticals market amounts to US$1,160.00m in 2024. The market is expected to grow annually by 5.93% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of US$354.80m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$12.92 are generated in 2024.
  • In the OTC Pharmaceuticals market, 2.2% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Iran is experiencing significant growth and development due to several factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the current state of the market.

Customer preferences in Iran are shifting towards self-medication and the use of over-the-counter pharmaceuticals. This is driven by a desire for convenience, cost-effectiveness, and increased access to healthcare products. Consumers are increasingly seeking out OTC medications for common ailments such as cold and flu symptoms, pain relief, and digestive issues.

This preference for self-medication is also influenced by the growing awareness and availability of OTC products in the market. Trends in the OTC Pharmaceuticals market in Iran reflect the global shift towards self-care and preventive healthcare. Consumers are becoming more proactive in managing their health and are willing to invest in OTC products that can help them prevent or alleviate minor health issues.

This trend is supported by the introduction of new OTC products that cater to specific consumer needs, such as vitamins and supplements, herbal remedies, and skincare products. Local special circumstances in Iran also contribute to the development of the OTC Pharmaceuticals market. The country has a large population with increasing disposable income, which allows consumers to spend more on healthcare products.

Additionally, the Iranian government has implemented policies to promote the domestic production of pharmaceuticals, including OTC medications. This has led to the growth of local manufacturers and increased availability of locally-produced OTC products. Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in Iran.

The country's healthcare system is undergoing reforms to improve access to healthcare services, including the availability of OTC medications. These reforms, coupled with a growing middle class and increasing urbanization, contribute to the expanding market for OTC pharmaceuticals. Furthermore, Iran has a young population that is becoming more health-conscious and willing to invest in preventive healthcare.

In conclusion, the OTC Pharmaceuticals market in Iran is experiencing growth and development due to customer preferences for self-medication, global trends towards self-care, local special circumstances, and underlying macroeconomic factors. As consumers seek convenience, cost-effectiveness, and increased access to healthcare products, the demand for OTC medications is expected to continue to rise in Iran.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)